- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04222296
Bimodal, CROS and Severe Profound Hearing Loss Study
Clinical Evaluation of Outcomes With Hearing Aid Parameters Designed for Adults With Severe-profound Hearing Loss and Unilateral Cochlear Implants in Bimodal (Cochlear Implant and Contralateral Hearing Instrument), CROS (Contralateral Routing of Signals) and Bilateral Amplification Strategies
The study will involve the comparison of three groups with severe-profound hearing loss. Patients with a Cochlear Implant only, patients with a cochlear implant and Hearing Aid, and finally patients with two hearing aids.
This will enable a comparison of standard fitting protocols against the new rationale using the same devices. Devices used for patients in all 3 groups are now available in standard of care, and can be kept afterwards should the patients wish.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will involve three groups of 20 patients per group. This first is experienced adult bimodal users of the AB system who have usable contralateral residual hearing. A clinical baseline and three research conditions will be evaluated.
The Naida CI Link HA (Link) will be fitted, tested and then optimised using a special bimodal fitting formula. Subjects will be allowed three months to acclimatize and will then be retested. The second research condition will evaluate the fully integrated bimodal system, where the microphone signals from CI and HA are shared and a bilateral beamformer is formed. A third intervention will involve modifying the CI settings to minimize the mis-match between frequencies delivered via the CI.
A second group with no aidable hearing on their non-implanted ear will also be studied. A contralateral routing of signal (CROS) device will send sounds on the non-implanted side. Tests will be made with and without CROS, as well as with directional microphone settings.
Finally as a control group, bilateral HA users will be tested with the similar HA fitting as used for the bimodal group.
This will enable a comparison of standard fitting protocols against the new rationale using the same devices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cambridge, United Kingdom, CB2 OQQ
- Addenbrooke's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Consistent unilateral user of an Advanced Bionics cochlear implant and a contralateral hearing aid for at least 6 months, ideally 12 months, and Bilateral severe to profound hearing loss (meeting NICE criteria for implantation-2009). (group 1)
- Consistent unilateral user of an Advanced Bionics cochlear implant for at least 6 months and ideally 12 months, with no useful contralateral hearing (group 2)
- Consistent user of bilateral hearing aids for at least six months (group 3) and bilateral severe profound hearing loss (80dB or worse at 2000 and 4000 Hz with speech discrimination of at least 50% IHR sentences live voice at 60dBA)
- First language English
- Post-lingual onset of severe to profound hearing loss
- No other handicaps that would interfere with participation in the study in the opinion of the Principle Investigator
Exclusion Criteria:
- Unstable cochlear implant or hearing aid fitting
- Using medication in an intermittent manner that might influence hearing levels
- Cognitive or psychological challenges that might lead to variations in attention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Cochlear Implant and Hearing Aid
Comparing performance of conventional hearing aid fitting to Phonak's Bimodal Fitting formula using the Phonak Naida Link hearing aid.
All patients are tested in a bimodal (hearing aid plus cochlear implant) setup.
Initial tests are completed with the Advanced Bionics Naida Q70 or Q90 sound processor and the patient's own hearing aid.
In this arm, a patient's own hearing aid is replaced with the Phonak Naida Link hearing aid to test if there is a benefit.
|
To determine whether new hardware and fitting strategy provides better sound quality or ease of use than generic hardware and fitting methods
|
Other: Cochlear Implant alone
To determine if the addition of a contralateral routing of signal (CROS) microphone on the un-implanted ear improves performance.
Baseline tests are completed with Advanced Bionics Naida Q70 or Q90 sound processors.
Patients are then given the Phonak Naida Link CROS aid to test if there is a benefit.
|
To determine whether new hardware and fitting strategy provides better sound quality or ease of use than generic hardware and fitting methods
|
Other: Hearing Aid and Hearing Aid
Comparing performance of conventional hearing aid fitting to a modified signal processing strategy more aligned with how a cochlear implant manages sound.
All patients are tested initially with their own hearing aids to obtain a baseline measurement.
Patients are then fitted with a modified Phonak hearing aid to determine if performance improves.
|
To determine whether new hardware and fitting strategy provides better sound quality or ease of use than generic hardware and fitting methods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sound Processing parameters
Time Frame: 24 months
|
ASSE score
|
24 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: James R Tysome, Cambridge University Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18/EE/0160
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Bilateral
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingSensorineural Hearing Loss, Bilateral | Bilateral Hearing LossFrance
-
Nantes University HospitalRecruitingProfound Bilateral Hearing LossFrance
-
Massachusetts Eye and Ear InfirmaryTerminatedBilateral Hearing Loss for Causes Other Than TumorsUnited States
-
Massachusetts Eye and Ear InfirmaryTerminatedBilateral Hearing Loss for Causes Other Than TumorsUnited States
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
CochlearVanderbilt University; NAMSA; AvaniaActive, not recruitingSensorineural Hearing Loss | Bilateral Hearing LossUnited States, Australia, New Zealand
-
MED-EL Elektromedizinische Geräte GesmbHCompletedSensorineural Hearing Loss, BilateralFrance
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Children's Hospital Medical Center, CincinnatiCompletedHearing Impairment | Sensorineural Hearing Loss, BilateralUnited States
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingSensorineural Hearing Loss, BilateralFrance
Clinical Trials on Fitting strategy of cohlear implant of hearing aid
-
University of Alabama, TuscaloosaUniversity of Alabama at BirminghamRecruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Aarhus University HospitalCompletedHearing Loss - ConductiveDenmark
-
Sonova AGCompletedHearing Loss, Bilateral Sensorineural, ProgressiveSwitzerland
-
VA Office of Research and DevelopmentCompletedHearing LossUnited States
-
Sonova AGSonova Audiological Care Australia Pty LtdCompletedHearing LossAustralia
-
Abbott Medical DevicesCompletedNon-left Bundle Branch Block | Ischemic or Non-ischemic CardiomyopathyUnited States
-
Sonova AGCompleted
-
Sonova AGCompleted
-
Hospital Universitario La PazMED-EL Elektromedizinische Geräte GesmbHRecruitingQuality of Life | Hearing Loss, Mixed | Bone Conduction DeafnessSpain